Metropolis Healthcare Ltd.
Metropolis Health.
₹ 0.00
0.00 (0.00)%
NSE
BSE
Healthcare
Small-cap - With a market cap of ₹113.57 Cr.
EX-Date | Purpose |
---|---|
27 05 2021 | Audited Results |
06 08 2021 | Quarterly Results & Inter alia, to consider and approve Proposal for raising funds either by way of private placement or preferential issue or public issue or through any other permissible mode and/or combination thereof, including by way of Qualified Institutions Placement, in accordance with applicable laws; and other matters |
10 11 2021 | Quarterly Results |
11 02 2022 | Quarterly Results & Interim Dividend |
24 05 2022 | Audited Results |
18 07 2022 | Inter alia, to consider and approve the revised Audited Standalone Financial results of the Company for the Quarter and Year ended March 31,2022 after taking on record the amalgamation of the 8(Eight) wholly owned Subsidiary Companies with the Company. |
10 08 2022 | Quarterly Results |
08 11 2022 | Quarterly Results |
10 02 2023 | Quarterly Results & Interim Dividend |
16 05 2023 | Audited Results(Cancelled) |
16 05 2023 | Audited Results |
02 08 2023 | Quarterly Results |
04 11 2023 | Quarterly Results & Interim Dividend |
02 02 2024 | Quarterly Results |
08 11 2024 | Quarterly Results |
09 12 2024 | Preferential Issue of shares Inter-alia to consider and approve the following: 1. Issuance of equity shares of the Company on a preferential basis, in accordance with the applicable laws, subject to the approval of shareholders of the Company and such other statutory approvals, as may be required. 2. Postal ballot notice for seeking shareholders approval in respect of the aforesaid proposal, if approved by the Board. |
04 02 2025 | Quarterly Results |
13 05 2025 | Audited Results |
07 08 2025 | Quarterly Results |